Cardiac Surgery Devices Market Size
Global Cardiac Surgery Devices Market reached US$ 2.3 billion in 2025 and is expected to reach US$ 3.5 billion by 2033 growing with a CAGR of 3.4% during the forecast period 2026–2033.
Cardiac surgery devices are used in the treatment of many cardiovascular diseases including congenital heart disease, arrhythmias, and heart valve disease. Cardiac surgery devices aid in the healing of structural problems in the circulatory system of the heart including damaged or clogged valves and arteries.
The global cardiac surgery devices market has witnessed significant growth in recent years due to the usage of cardiac and vascular surgery devices such as pacemakers, implantable cardioverter defibrillators (ICDs), heart valves, balloon catheters, and stents as they play a key role in managing and treating cardiovascular diseases.
Furthermore, significant growth drivers such as increasing technological advancements, product launches, and favorable reimbursement policies give rise to future market growth. Significant key players like Medtronic plc, Terumo Corporation, LivaNova Plc., Abbott Laboratories, Murray Surgical Limited, Boston Scientific Corporation, and others are actively operating in the market.
Market Scope
| Metrics | Details |
| CAGR | 3.4% |
| Size Available for Years | 2023-2033 |
| Forecast Period | 2026-2033 |
| Data Availability | Value (US$) |
| Segments Covered | Product, Procedure, Application, End User, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Others key Insights. |
For more details on this report Request for Sample
Market Dynamics
The cardiac surgery devices market is experiencing steady growth driven by the increasing prevalence of cardiovascular diseases, including coronary artery disease, heart valve disorders, and congenital heart defects. The rising aging population, coupled with unhealthy lifestyles such as poor diet, smoking, and physical inactivity, is significantly contributing to the growing demand for cardiac surgical interventions. Advancements in medical technology, including minimally invasive and robotic-assisted surgical devices, are improving procedural outcomes, reducing recovery times, and enhancing patient safety. Additionally, the expansion of healthcare infrastructure, increasing healthcare expenditure, and growing adoption of advanced surgical techniques are further supporting market growth globally.
However, the market faces several challenges that may restrain its expansion. High costs associated with cardiac surgery devices and procedures remain a major barrier, particularly in developing regions with limited healthcare budgets. Stringent regulatory requirements and lengthy approval processes can delay product launches and increase compliance costs for manufacturers. Furthermore, the risk of surgical complications, shortage of skilled cardiac surgeons, and limited access to advanced healthcare facilities in rural areas can hinder adoption. Competition from alternative treatment options such as medication and catheter-based interventions, along with reimbursement uncertainties, also pose challenges to the overall growth of the cardiac surgery devices market.
Market Segment Analysis
The global cardiac surgery devices market is segmented based on product, procedure, application, end users, and region.
Catheters from the Product Segment accounted for Approximately 47.2% of the global cardiac surgery devices market share.
The catheterization procedure is typically carried out in patients by using various catheters with certain congenital heart defects, such as transposition of the great arteries or pulmonary atresia, where there is an abnormal communication or inadequate blood flow between the atria. The demand for catheters is driven by the increasing incidence of cardiovascular diseases.
Recent Developments
February 2026: In North America, particularly the United States, rising prevalence of cardiovascular diseases and increasing surgical volumes significantly accelerated demand for cardiac devices, supported by strong healthcare infrastructure and growing adoption of advanced surgical technologies.
January 2026: In Europe, countries such as Germany, France, and the United Kingdom strengthened investments in minimally invasive cardiac procedures, driving adoption of advanced surgical innovation such as transcatheter heart valves and robotic-assisted systems.
December 2025: In Asia Pacific, especially China, India, and Japan, expanding healthcare infrastructure, rising patient population, and increasing awareness of cardiac care positioned the region as the fastest-growing market, boosting regional expansion of cardiac surgery devices.
November 2025: In the Middle East & Africa, growing investments in specialized cardiac hospitals and increasing access to surgical care supported gradual adoption of advanced cardiac devices, strengthening healthcare development across emerging economies.
October 2025: Globally, rapid advancements in minimally invasive and transcatheter procedures, including valve replacement and repair technologies, significantly enhanced patient outcomes and reduced recovery time, accelerating technology advancement in cardiac surgery devices.
September 2025: Across global markets, increasing shift toward precision-driven and hybrid surgical techniques, including robotic-assisted and beating-heart procedures, gained strong momentum, driving procedure efficiency and improving surgical success rates.
The market is steadily evolving toward minimally invasive, precision-driven, and technology-enabled cardiac care ecosystems, with strong growth driven by rising cardiovascular disease burden, increasing surgical volumes, and continuous advancements in transcatheter and robotic-assisted technologies, positioning cardiac surgery devices as a critical component of modern cardiovascular treatment.
Cardiac Surgery Devices Companies
The major global players in the market include Medtronic Plc., Terumo Corporation, LivaNova Plc., Abbott Laboratories, Murray Surgical Limited, Boston Scientific Corporation, Getinge AB, Wexler Surgical, Lepu Medical Technology Co. Ltd, and Gore Medical Inc. among others.
By Product
- Beating Heart Surgery Systems
- Stabilizers
- Positioners
- Cardiopulmonary Bypass Equipment
- Arterial cannula
- Venous cannula
- Oxygenators
- Catheters
- Balloon catheter
- Ablation Catheter
- Drainage Catheter
- Perfusion Disposables
- Arterial Filters
- Connectors
- Hemoconcentrator
- Others
By Procedure
- Coronary Artery Bypass Grafting
- Minimally Invasive Surgery
- Others
By Application
- Congenital Heart Disease
- Coronary Artery Disease
- Arrhythmias
- Heart Valve Disease
- Rheumatic Heart Disease
- Aortic Aneurysm
- Congestive Heart Failure
- Others
By End Users
- Hospital
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
Why Purchase the Report?
- To visualize the global cardiac surgery devices market segmentation based on product, procedure, application, end users, and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of global cardiac surgery devices market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global cardiac surgery devices market report would provide approximately 69 tables, 70 figures, and 195 Pages.
Target Audience
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
